A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.
about
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A phase II trial of riluzole, ...... tients with advanced melanoma.
@en
A phase II trial of riluzole, ...... tients with advanced melanoma.
@nl
type
label
A phase II trial of riluzole, ...... tients with advanced melanoma.
@en
A phase II trial of riluzole, ...... tients with advanced melanoma.
@nl
prefLabel
A phase II trial of riluzole, ...... tients with advanced melanoma.
@en
A phase II trial of riluzole, ...... tients with advanced melanoma.
@nl
P2093
P2860
P50
P356
P1476
A phase II trial of riluzole, ...... tients with advanced melanoma.
@en
P2093
Ann W Silk
Byeong-Seon Jeong
Evita Sadimin
Hongxia Lin
Jiadong Li
Liesel Dudek
Michael Kane
Suzie Chen
Weichung J Shih
P2860
P304
P356
10.1111/PCMR.12694
P577
2018-02-17T00:00:00Z